FOXA2 and colorectal carcinoma: RNA‐Seq analysis was then conducted to examine the gene expression in sh‐NC and sh‐FOXA2 HCT‐116 cells to explore the underlying mechanisms revealing the oncogenic potential of FOXA2 in CRC cells.